Sangeeta Paul

Sangeeta Paul

BSc Pharmacy, MSc Pharmacy, Ph.D. Pharmacology

Sangeeta Paul is a researcher and medical writer based in Gurugram, India. Her academic background is in Pharmacy; she has a Bachelor’s in Pharmacy, a Master’s in Pharmacy (Pharmacology), and Ph.D. in Pharmacology from Banasthali Vidyapith, Rajasthan, India. She also holds a post-graduate diploma in Drug regulatory affairs from Jamia Hamdard, New Delhi, and a post-graduate diploma in Intellectual Property Rights, IGNOU, India.

She has extensive experience in pre-clinical research as a part of her research projects undertaken at the Central Drug Research Institute (CDRI), Lucknow, India. Her research works involved the assessment of phytoconstituents derived from berry-bearing plants on learning and memory-enhancing activity using in vivo and in vitro models.

Sangeeta has co-authored research papers published in reputed journals like Springer Nature and has also served as a reviewer for peer-reviewing manuscripts of reputed journals. She is also a certified Publon Peer Reviewer.

Sangeeta has presented many posters and oral presentations in scientific conferences and attended many scientific workshops. She has worked as a lecturer and research analyst and is passionate about health, secondary research, and medical writing. When she is not working, she enjoys traveling and cooking.

Articles from Sangeeta

SARS-CoV-2 mRNA vaccines may prevent COVID-19-associated mechanical ventilation and death

SARS-CoV-2 mRNA vaccines may prevent COVID-19-associated mechanical ventilation and death

The relationship between numerous pandemic-related stressors and psychological distress facets in Israel

The relationship between numerous pandemic-related stressors and psychological distress facets in Israel

Molecular dynamic simulations unveil conformational dynamics of SARS-CoV-2 spike protein RBD and ACE2 receptor

Molecular dynamic simulations unveil conformational dynamics of SARS-CoV-2 spike protein RBD and ACE2 receptor

Study investigates risk exposure models for negative COVID-19 impact in youths

Study investigates risk exposure models for negative COVID-19 impact in youths

Early treatment of COVID-19 in high-risk children and adolescents infected with the Omicron variant of SARS-CoV-2

Early treatment of COVID-19 in high-risk children and adolescents infected with the Omicron variant of SARS-CoV-2

Presence of zoonotic pathogens in wildlife market for human consumption in Laos

Presence of zoonotic pathogens in wildlife market for human consumption in Laos

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

Researchers develop extraction-free saliva RT-LAMP assay for workplace surveillance of SARS-CoV-2

Researchers develop extraction-free saliva RT-LAMP assay for workplace surveillance of SARS-CoV-2

Evidence of COVID-19 impacts on glycated hemoglobin levels in a real-world clinical cohort

Evidence of COVID-19 impacts on glycated hemoglobin levels in a real-world clinical cohort

Identification of linear B cell epitopes in the SARS-CoV-2 proteome that are conserved in humans coronaviruses

Identification of linear B cell epitopes in the SARS-CoV-2 proteome that are conserved in humans coronaviruses

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.